McKesson Hit With FCA Suit Alleging Misbranded Drugs

By Dave Simpson · April 4, 2018, 10:00 PM EDT

A medical company is accusing pharmaceutical distribution company McKesson Corp. of opening deliberately overfilled sterile vials of drugs, skimming the excess medicine and then transferring the drugs into single-dose pre-filled syringes in a...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

United States of America et al v. McKesson Corporation et al

Case Number

1:12-cv-06440

Court

New York Eastern

Nature of Suit

Other Statutes: False Claims Act

Date Filed

March 09, 2012